REGISTRATION OF SUBJECT FOR DISSERTATION

Methotrexate (7.5 to 15 mg orally or 15 mg intramuscularly or subcutaneously once weekly), together with folic acid (1 mg daily) is probably the best initial choice as it is both efficacious and steroid sparing in the treatment of scleritis and has a favorable side effect profile and lower oncogenic potential as compared to cytotoxic drugs (cyclophosphamide and chlorambucil). ................
................